SCHEDULE 13G: AmTrust Entities Disclose 9.8% Passive Stake in 180 Life Sciences Corp.

AmTrust Financial Services, Inc. and its subsidiary AmTrust International Underwriters DAC have disclosed a passive 9.8% beneficial ownership stake in 180 Life Sciences Corp.

Summary

• AmTrust Financial Services, Inc. (AFSI) and its subsidiary, AmTrust International Underwriters DAC (AIUDAC), collectively referred to as the 'Reporting Persons,' have filed a Schedule 13G.
• The filing indicates that the Reporting Persons beneficially own an aggregate of 509,707 shares of common stock of 180 Life Sciences Corp.
• This ownership represents approximately 9.8% of 180 Life Sciences Corp.'s outstanding shares, based on 5,185,780 shares outstanding as of March 31, 2025, as disclosed in the issuer's Annual Report on Form 10-K.
• AFSI holds sole voting and dispositive power over all 509,707 shares, while AIUDAC, as a subsidiary of AFSI, holds shared voting and dispositive power over the same amount.
• The Reporting Persons certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of 180 Life Sciences Corp., indicating a passive investment.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of a passive beneficial ownership stake, providing factual information without indicating significant positive or negative developments for the issuer's operations or financial health.

Positives

• The disclosure of a significant passive stake by institutional investors like AmTrust Financial Services, Inc. may be perceived as a signal of confidence in 180 Life Sciences Corp.'s long-term prospects.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the issuer's future operations or financial performance, as it is a beneficial ownership disclosure.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a routine disclosure of a passive investment stake by a financial services entity in a life sciences company. It does not indicate any specific strategic industry trend or competitive action, but rather a portfolio investment.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by institutional investors like AmTrust Financial Services, Inc. may be perceived as a signal of confidence in 180 Life Sciences Corp., potentially influencing investor sentiment.

Next Steps

• The Reporting Persons will be required to file amendments to this Schedule 13G if there are material changes to their beneficial ownership or the nature of their investment.

Key Dates

Keywords

180 Life Sciences Corp., AmTrust Financial Services, AmTrust International Underwriters, Schedule 13G, beneficial ownership, common stock, passive investment, institutional ownership